Literature DB >> 19497502

Predicting ambulation status one year after lower extremity bypass.

Philip P Goodney1, Donald S Likosky, Jack L Cronenwett.   

Abstract

INTRODUCTION: Surgeons must weigh the morbidity of lower extremity bypass (LEB) with the likelihood of a functional outcome postoperatively. We developed a model to predict ambulation status 1 year after LEB.
METHODS: We analyzed a prospective registry of 1561 LEB procedures performed for occlusive disease (2003-2005) in 1400 patients (50 surgeons, 11 hospitals). Ambulation status was assessed preoperatively, at discharge, and at 1-year by life-table analysis. Cox proportional hazards models were used to determine predictors of ambulation status 1 year postoperatively.
RESULTS: The indication for surgery was claudication in 25% and critical limb ischemia (CLI) in 75%. Claudicant patients had higher primary (79% vs 73%, P < .001) and secondary (87% vs 81%, P < .001) graft patency rates and were more likely to be alive and ambulatory 1 year postoperatively (96% vs 81%, P < .001) than CLI patients. Amputation rates were 12% for CLI patients and 1% for claudicant patients (P < .001). All claudicant patients walked before surgery, and the 95% who survived 1 year postoperatively remained ambulatory. Preoperatively, 93% of CLI patients were ambulatory, and 88% of the survivors at 1 year remained ambulatory. The risk of dying or being nonambulatory 1 year postoperatively was increased in patients who were nonambulatory preoperatively (hazard ratio [HR], 1.5; 95% confidence interval [CI], 1.3-1.6; P < .0001), by increasing age of 70-79 (HR, 1.8; 95% CI, 1.2-2.6; P < .007) and 80-89 years (HR, 2.3; 95% CI, 1.5-3.7; P < .0001), by CLI (HR, 2.0; 95% CI, 1.2-3.4; P < .007), by postoperative myocardial infarction (HR, 2.5; 95% CI, 1.6-4.1; P < .001), and by major amputation (HR, 2.9; 95% CI, 2.1-4.1; P < .001). Graft thrombosis during follow-up (HR, 1.6; 95% CI, 1.1-1.8; P < .003) and living in a nursing home preoperatively (HR, 3.5; 95% CI, 1.5-7.8; P < .003) were independently associated with a higher risk of being nonambulatory at 1 year.
CONCLUSIONS: Ambulatory and independent living status are well preserved after LEB. Risk factors of age, preoperative ambulatory ability, independent living status, CLI, graft patency, and amputation help to predict ambulatory status 1 year postoperatively. The likelihood of death or nonambulatory status at 1 year was <5% in patients with none of these risk factors to nearly 50% in patients with three or more risk factors. These variables can be used to inform decision making about whether patients should undergo LEB.

Entities:  

Mesh:

Year:  2009        PMID: 19497502     DOI: 10.1016/j.jvs.2009.02.014

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  19 in total

1.  Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia.

Authors:  Jessica P Simons; Philip P Goodney; Brian W Nolan; Jack L Cronenwett; Louis M Messina; Andres Schanzer
Journal:  J Vasc Surg       Date:  2010-04-24       Impact factor: 4.268

2.  Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.

Authors:  Neal R Barshes; Panos Kougias; C Keith Ozaki; Philip P Goodney; Michael Belkin
Journal:  J Vasc Surg       Date:  2014-03-20       Impact factor: 4.268

3.  Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study.

Authors:  Lawrence Oresanya; Shoujun Zhao; Siqi Gan; Brant E Fries; Philip P Goodney; Kenneth E Covinsky; Michael S Conte; Emily Finlayson
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

Review 4.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

5.  Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.

Authors:  Kentaro Inoue; Toshihiro Onohara; Keita Mikasa; Tadashi Furuyama
Journal:  Surg Today       Date:  2016-04-18       Impact factor: 2.549

6.  Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice.

Authors:  Philip P Goodney; Andres Schanzer; Randall R Demartino; Brian W Nolan; Nathanael D Hevelone; Michael S Conte; Richard J Powell; Jack L Cronenwett
Journal:  J Vasc Surg       Date:  2011-02-18       Impact factor: 4.268

7.  Predicting functional status following amputation after lower extremity bypass.

Authors:  Bjoern D Suckow; Philip P Goodney; Robert A Cambria; Daniel J Bertges; Jens Eldrup-Jorgensen; Jeffrey E Indes; Andres Schanzer; David H Stone; Larry W Kraiss; Jack L Cronenwett
Journal:  Ann Vasc Surg       Date:  2012-01       Impact factor: 1.466

8.  An endovascular model of ischemic myopathy from peripheral arterial disease.

Authors:  Chandler A Long; Lucas H Timmins; Panagiotis Koutakis; Traci T Goodchild; David J Lefer; Iraklis I Pipinos; George P Casale; Luke P Brewster
Journal:  J Vasc Surg       Date:  2016-09-29       Impact factor: 4.268

9.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

10.  The influence of gender on functional outcomes of lower extremity bypass.

Authors:  Reshma P Duffy; Julie E Adams; Peter W Callas; Andres Schanzer; Philip P Goodney; Michael A Ricci; Jack L Cronenwett; Daniel J Bertges
Journal:  J Vasc Surg       Date:  2014-09-19       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.